Temporal Changes in Bone Composition, Architecture, and Strength Following Estrogen Deficiency in Osteoporosis
- 485 Downloads
Using an ovariectomized (OVX) ovine model, we provide an analysis of the timing of changes in bone following estrogen deficiency. The expression of genes known to regulate osteoclastogenesis, matrix production, and mineralization, as measured by real-time RT-PCR, was significantly increased by 12 months; and increased expression was maintained through to 31 months post-OVX compared to controls. FTIR spectroscopy confirmed that mineralized crystals were less mature than in controls 12 months post-OVX and were even less so by 31 months. The mineral-to-matrix ratio was significantly reduced by 31 months, while the ratio of mature to immature collagen cross-linking was initially increased at 12 months and subsequently reduced at 31 months post-OVX. In contrast, trabecular number, thickness, and separation were unchanged at 12 months. Significant reductions in trabecular number and thickness and a significant increase in trabecular separation were observed 31 months after OVX. Most notably perhaps these combined changes led to a significant reduction in the compressive strength of trabecular bone after 31 months. The results indicate that there is an initial increase in bone turnover, which is accompanied by a change in bone composition. This is followed by a continued increase in bone resorption and relative reduction in bone formation, leading to deterioration in bone microarchitecture. Ultimately, these cumulative changes led to a significant reduction in the compressive strength of bones following 31 months of estrogen deficiency. These findings provide important insight into the time sequence of changes during osteoporosis.
KeywordsOsteoporosis Microarchitecture Bone composition Biomechanical property Animal model
The authors acknowledge Dr. Gerald Atkins for helpful discussion and Ms. Lena Truong, Ms. Katie Reeve-Arnold, and Ms. Laura Corrigan for technical assistance. Funding for this study was granted by the Health Research Board under grant numbers RP/2004/229 and RP/2007/179 and by the Higher Education Authority in Ireland under PRTLI Cycle III.
- 4.Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89(2):309–319PubMedCrossRefGoogle Scholar
- 8.Brennan M, Gleeson JP, Browne M, O’Brien FJ, Thurner PJ, McNamara LM (2011) Site specific increase in heterogeneity of trabecular bone tissue mineral during estrogen deficiency. Eur Cell Mater 15(21):396–406Google Scholar
- 36.Gadeleta SJ, Boskey AL, Paschalis E, Carlson C, Menschik F, Baldini T, Peterson M, Rimnac CM (2000) A physical, chemical, and mechanical study of lumbar vertebrae from normal, ovariectomized, and nandrolone decanoate-treated cynomolgus monkeys (Macaca fascicularis). Bone 27(4):541–550PubMedCrossRefGoogle Scholar